Protagonist Therapeutics, Inc. (PTGX)
136.24
+0.34
(+0.25%)
USD |
NASDAQ |
Nov 10, 16:00
136.24
0.00 (0.00%)
After-Hours: 17:35
Protagonist Therapeutics Price : 136.24 for Nov. 10, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 09, 2026 | 135.02 | 137.93 | 131.31 | 135.90 | 607112.0 |
| Nov 06, 2026 | 135.26 | 138.40 | 128.00 | 132.04 | 972946.0 |
| Nov 05, 2026 | 142.56 | 143.30 | 134.39 | 135.26 | 584679.0 |
| Nov 04, 2026 | 145.61 | 145.61 | 138.39 | 143.37 | 777232.0 |
| Nov 03, 2026 | 140.73 | 144.26 | 139.91 | 140.24 | 674723.0 |
| Nov 02, 2026 | 145.74 | 146.00 | 139.35 | 139.37 | 486660.0 |
| Oct 30, 2026 | 144.34 | 146.00 | 142.54 | 144.85 | 322566.0 |
| Oct 29, 2026 | 144.03 | 146.44 | 142.87 | 144.34 | 325558.0 |
| Oct 28, 2026 | 139.35 | 143.26 | 138.29 | 142.14 | 318459.0 |
| Oct 27, 2026 | 140.08 | 142.37 | 137.91 | 141.12 | 865926.0 |
| Oct 26, 2026 | 139.24 | 142.00 | 137.30 | 140.32 | 823278.0 |
| Oct 23, 2026 | 136.89 | 139.52 | 135.00 | 138.43 | 409357.0 |
| Oct 22, 2026 | 137.49 | 141.38 | 136.07 | 139.53 | 404387.0 |
| Oct 21, 2026 | 139.71 | 141.85 | 137.96 | 138.08 | 990174.0 |
| Oct 20, 2026 | 135.87 | 140.82 | 134.32 | 137.99 | 774485.0 |
| Oct 19, 2026 | 130.09 | 134.97 | 128.01 | 134.44 | 654178.0 |
| Oct 16, 2026 | 136.16 | 136.56 | 126.39 | 128.75 | 886813.0 |
| Oct 15, 2026 | 136.72 | 139.11 | 136.02 | 136.55 | 707740.0 |
| Oct 14, 2026 | 138.06 | 141.13 | 135.62 | 136.28 | 679101.0 |
| Oct 13, 2026 | 146.00 | 146.00 | 137.81 | 138.49 | 1.032M |
| Oct 12, 2026 | 145.83 | 152.18 | 143.69 | 144.88 | 898518.0 |
| Oct 09, 2026 | 139.91 | 146.30 | 138.95 | 143.73 | 763099.0 |
| Oct 08, 2026 | 139.57 | 142.18 | 137.99 | 139.91 | 1.000M |
| Oct 07, 2026 | 137.34 | 144.10 | 137.25 | 140.92 | 927270.0 |
| Oct 06, 2026 | 140.34 | 141.00 | 136.09 | 138.69 | 635716.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 280.71 |
| AbbVie, Inc. | 293.78 |
| BioMarin Pharmaceutical, Inc. | 57.13 |
| Gilead Sciences, Inc. | 170.92 |
| Nektar Therapeutics | 37.81 |
Price Related Metrics
| PE Ratio | 28.86 |
| PS Ratio | 17.12 |
| PEG Ratio | 0.0447 |
| Price to Book Value | 8.190 |
| Price to Free Cash Flow | 86.52 |
| Earnings Yield | 3.47% |
| Market Cap | 8.885B |
| PEGY Ratio | 0.0447 |
| Operating PE Ratio | 29.23 |
| Normalized PE Ratio | 28.86 |